Valérie Sabourin

McGill University — Canada

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index287citations53works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Research and Treatments(17), Cancer, Hypoxia, and Metabolism(9), Mitochondrial Function and Pathology(5), RNA modifications and cancer(5), Cancer Cells and Metastasis(4)

Publications53 total

Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics
2026Open Access
Author response: Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics
2026Open Access
Reviewer #2 (Public review): Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics
2026Open Access
Reviewer #1 (Public review): Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics
2026Open Access
Complex I inhibition combined with TLR activation in the breast tumor microenvironment educates cytotoxic neutrophils
Science Advances·2025· 3 citedOpen Access
Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics
2025Open Access
Author response: Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics
2025Open Access
Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics
2025Open Access
Figure S7 from The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple-Negative Breast Cancer by Attenuating TGFβ Signaling
2024Open Access
Figure S2 from The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple-Negative Breast Cancer by Attenuating TGFβ Signaling
2024Open Access
Figure S6 from The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple-Negative Breast Cancer by Attenuating TGFβ Signaling
2024Open Access
Figure S3 from The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple-Negative Breast Cancer by Attenuating TGFβ Signaling
2024Open Access
Figure S1 from The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple-Negative Breast Cancer by Attenuating TGFβ Signaling
2024Open Access
Figure S5 from The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple-Negative Breast Cancer by Attenuating TGFβ Signaling
2024Open Access
Figure S4 from The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple-Negative Breast Cancer by Attenuating TGFβ Signaling
2024Open Access
Tables S1 and S2 from The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple-Negative Breast Cancer by Attenuating TGFβ Signaling
2024Open Access
Figure S7 from The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple-Negative Breast Cancer by Attenuating TGFβ Signaling
2024Open Access
Figure S2 from The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple-Negative Breast Cancer by Attenuating TGFβ Signaling
2024Open Access
Figure S3 from The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple-Negative Breast Cancer by Attenuating TGFβ Signaling
2024Open Access
Figure S4 from The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple-Negative Breast Cancer by Attenuating TGFβ Signaling
2024Open Access
page 1 of 3Next →

Frequent Co-authors

Josie Ursini‐Siegel(49), Claudia L. Kleinman(30), Peter M. Siegel(30), Steven Hébert(28), Matthew G. Annis(21), HaEun Kim(21), Young Kyuen Im(19), Ryuhjin Ahn(18), Caitlynn Mirabelli(18), Michael Witcher(17), John Heath(17), Steven Findlay(16), Alexandre Orthwein(16), Jacqueline R. Ha(15), Eduardo Cepeda Cañedo(13), Daina Avizonis(12), Ivan Topisirović(10), Harvey W. Smith(10), William J. Muller(10), Emma Ciccolini(10)